GlassScriptPhysician profile
Louis Lam
NPI 1205132446
$6,424.22
in general payments reported to CMS, 2019-2025
9 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2021: $645 · 2022: $3,946 · 2023: $334 · 2024: $676 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.90 |
| Education | $129.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,890.85 | 2022-2024 | |
| Boston Scientific Corporation | $836.63 | 2019-2023 | |
| Galvanize Therapeutics, INC | $538.78 | 2022-2025 | Aliya System |
| Ethicon INC. | $474.47 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $256.22 | 2024-2025 | Tezspire |
| Broncus Medical | $177.07 | 2019 | |
| Getinge USA Sales, LLC | $142.86 | 2019 | |
| Covidien LP | $95.16 | 2019 | |
| Medtronic, INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.